Search Results
1 - Cordis Corporation Announces Agreement with Boston Scientific to Settle Selected Stent Litigation Cases
BRIDGEWATER, N.J.-(Business Wire)-September 29, 2009 - Cordis Corporation (“Cordis”) announced today that it has reached an agreement with Boston Scientific (“Boston”) resolving its Palmaz infringement suit relating to Boston’s NIR stent, settling several other cardiology-related cases...
2 - Research and Markets: Blistering Skin Diseases, 1st Edition - a Comprehensive Guide to the Diagnosis and Treatment of Various Blistering Skin Diseases
DUBLIN-(Business Wire)-September 29, 2009 - Research and Markets has announced the addition of the "Blistering Skin Diseases, 1st Edition" report to their offering. This book aims to provide the definitive guide to the diagnosis and treatment of various blistering skin diseases. It offers the reader...
3 - Research and Markets: Clinical Neurology, 1st Edition - a Concise Yet Comprehensive Volume, Providing a Fresh Approach to Clinical Neurology
DUBLIN-(Business Wire)-September 29, 2009 - Research and Markets has announced the addition of the "Clinical Neurology, 1st Edition" report to their offering. Recent advances in neuroimaging, basic neuroscience, molecular genetics and their consequent therapeutic developments, have helped clinical...
4 - Study Indicates Effectiveness of Online Screenings in Connecting Individuals at Risk for Depression to Treatment
BOSTON-(Business Wire)-September 29, 2009 - Screening for Mental Health, Inc., the leading nonprofit provider of online and in-person mental health screening programs, today released results from a follow-up study of participants in the 2008 National Depression Screening Day® (NDSD) online program...
5 - ABL and Evivar Medical Enter into Agreements to Form a Global Strategic Partnership and IP Cross-Licensing for Disease Management and Personalized Healthcare of Hepatitis B and HIV Infections
LUXEMBOURG & MELBOURNE, Australia-(Business Wire)-September 29, 2009 - ABL, S.A. and Evivar Medical Pty Ltd today announced the completion of agreements to cross-licence their respective intellectual property portfolios and to form strategic alliances based on the use of their proprietary...
6 - Study Shows AFRESA® Provides Rapid Suppression of Endogenous Glucose Production in Diabetes Patients
VIENNA-(Business Wire)-September 29, 2009 - AFRESA® (insulin human [rDNA origin]) Inhalation Powder is a well-tolerated, ultra rapid acting insulin able to more closely replicate normal glucose suppression than currently available insulins, according to data presented at the 45th Annual Meeting...
7 - Verilogue to Present on Patient-Physician Vaccine Discussions at 2009 International Conference on Communication in Healthcare
-(Business Wire)-September 29, 2009 - Verilogue: WHO: David Franke, Verilogue Director of Linguistic Insights and Analytics WHAT: Franke will deliver a presentation entitled “Patient Autonomy, Clinical Objectivity and the Ethics of Physician Persuasion in Vaccine Discussions.” Recently...
8 - Pfizer Receives Approval from China’s Ministry of Commerce for Pending Wyeth Acquisition
NEW YORK-(Business Wire)-September 29, 2009 - Pfizer Inc (NYSE:PFE) today announced that China’s Ministry of Commerce has approved the company’s pending acquisition of Wyeth. The Ministry’s decision includes Pfizer’s commitment to divest certain animal health assets in China. “We are...
9 - New Poll Reveals a Majority of Americans View H1N1 as a Serious Health Hazard, Yet Almost 70% Do Not Definitively Plan to Get the Vaccine
BURLINGTON, Mass.-(Business Wire)-September 29, 2009 - A majority (58%) of Americans believe that the H1N1 flu is a serious health hazard, according to a new survey released today by Silverlink Communications, Inc. This represents a marked increase as compared to May 2009, when 47% of Americans held...
10 - iPosture Announces Golf-Pro Posture Device for Golfers
MEMPHIS, Tenn.-(Business Wire)-September 29, 2009 - Memphis-based neurologist Moacir Schnapp, M.D., creator of the iPosture, today announced the launch of his posture improvement device for golfers – the iPosture Golf-Pro. The small device was created to help golfers improve their posture during...
11 - Premier Healthcare Alliance Names AeroScout as the Exclusive Provider of RFID Asset Tracking and Management Solutions for its ASCEND Program
REDWOOD CITY, Calif.-(Business Wire)-September 29, 2009 - Following the recent announcement of an agreement between Premier Purchasing Partners, L.P., and AeroScout, the Premier healthcare alliance announced today that it has selected AeroScout as the sole source provider of RFID Asset Tracking...
12 - Synta Pharmaceuticals Initiates Fourth Trial of STA-9090, a Novel Synthetic Small Molecule Hsp90 Inhibitor
LEXINGTON, Mass.-(Business Wire)-September 29, 2009 - Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it has initiated a Phase 1/2 clinical...
13 - Aurora Breast MRI of Sarasota and Clear Channel Radio, Partner for “Change for Change” Fundraising Event
SARASOTA, Fla.-(Business Wire)-September 29, 2009 - Aurora Breast MRI of Sarasota today announced it has partnered with Clear Channel Radio for a fundraising effort to benefit The Wellness Community of Southwest Florida. The fundraiser, titled “Change for Change,” will consist of a series of...
14 - Research and Markets: Small Animal Gastroenterology
DUBLIN-(Business Wire)-September 29, 2009 - Research and Markets has announced the addition of the "Small Animal Gastroenterology" report to their offering. Great advances have been made recently in small animal gastroenterology. This book has been written by authors from around the world with a...
15 - BioClinica™ Showcases Clinical Data Management at SCDM Annual Conference
NEWTOWN, Pa.-(Business Wire)-September 29, 2009 - BioClinica, Inc., (NASDAQ: BIOC) a leading global provider of clinical trial services, is helping to advance the discipline of clinical data management and will demonstrate integrated eClinical and imaging data management technology and expertise...
16 - Elan Corporation Plc Announces Cash Tender for Outstanding US$850M in Aggregate Principal Amount of 2011 Fixed Rate Notes
DUBLIN, Ireland-(Business Wire)-September 29, 2009 - Elan Corporation, plc ("Elan") today announced that its wholly-owned subsidiaries, Elan Finance public limited company and Elan Finance Corp., are commencing a cash tender offer (the “Tender Offer”) for the outstanding US$850 million in...
17 - Seattle Cancer Care Alliance, ProCure to Develop Proton Therapy Center
SEATTLE & BLOOMINGTON, Ind.-(Business Wire)-September 29, 2009 - The development of a proton therapy center in the Pacific Northwest has taken a significant step forward with the signing of a letter of intent between the Seattle Cancer Care Alliance (SCCA) and ProCure Treatment Centers Inc...
18 - Inc. Magazine Names InVivo Therapeutics CEO Frank Reynolds one of ‘America’s Most Innovative Entrepreneurs’
CAMBRIDGE, Mass.-(Business Wire)-September 28, 2009 - Frank Reynolds, InVivo Therapeutics President and CEO, has been identified as one of ‘‘America’s most innovative entrepreneurs’ in the October 2009 issue of Inc. Magazine. In the article entitled “The New and Improved You,” Inc...
19 - Flexible Stenting Solutions, Inc. Receives Conditional IDE Approval for FlexStent® Femoropopliteal Self Expanding Stent System
EATONTOWN, N.J.-(Business Wire)-September 28, 2009 - Flexible Stenting Solutions Inc. (“FSS”), a leading developer of next generation peripheral arterial and biliary stents, announced today that it has received Conditional Investigational Device Exemption (IDE) approval for its FlexStent...
20 - Research and Markets: Parkinson's Disease: Clinician's Desk Reference
DUBLIN-(Business Wire)-September 28, 2009 - Research and Markets has announced the addition of the "Parkinson's Disease: Clinican's Desk Reference, 1st Edition" report to their offering. The new series 'Clinician's Desk Reference', designed as concise up-to-date volumes on key conditions for...
